Literature DB >> 10669127

A review of zygomycosis due to Basidiobolus ranarum.

H C Gugnani1.   

Abstract

Zygomycosis due to Basidiobolus ranarum (entomophthoromycosis basidiobolae, subcutaneous zygomycosis, subcutaneous phycomycosis, basidiobolomycosis) is a granulomatous infection of the skin and subcutaneous tissues characterized by the formation of fluctuant firm and non-tender swellings, generally on the extremities, trunk and rarely other parts of the body. The causative agent is common in soil, decaying vegetable matter, and the gastrointestinal tracts of amphibians, reptiles, fish and bats. It is presumed that infection is acquired through exposure to B. ranarum following minor trauma to skin or insect bites. The disease usually occurs in children, less often in adolescents and rarely in adults. Males are much more frequently affected than females. Laboratory diagnosis is based on histopathology and culture. The typical histopathological feature is the presence of thin-walled, broad often aseptate hyphae or hyphal fragments with an eosinophilic sheath, frequently phagocytized within giant cells. Basidiobolus ranarum is known to produce several enzymes, e.g. lipase and protease that probably play roles in the pathogenesis of infections caused by this mould. An immunological test has been developed for specific diagnosis of the disease. Though potassium iodide (KI) has been the traditional drug employed in the treatment of infections by B. ranarum, several other drugs, viz amphotericin B, cotrimoxazole, ketoconazole, itraconazole and fluconazole have been successfully tried.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10669127     DOI: 10.1023/a:1007656818038

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  44 in total

1.  PHYCOMYCOSIS IN IBADAN, WESTERN NIGERIA. TWO POSTMORTEM REPORTS.

Authors:  G M EDINGTON
Journal:  Trans R Soc Trop Med Hyg       Date:  1964-05       Impact factor: 2.184

2.  Extracellular enzyme activities by Basidiobolus and Conidiobolus isolates on solid media.

Authors:  J I Okafor; H C Gugnani; D Testratke; B G Yangoo
Journal:  Mykosen       Date:  1987-09

3.  Isolation of Basidiobolus meristosporus from natural sources.

Authors:  J Coremans-Pelseneer
Journal:  Mycopathol Mycol Appl       Date:  1973-03-15

4.  Mycotic flora of the intestine and other internal organs of certain reptiles and amphibians with special reference to characterization of Basidiobolus isolates.

Authors:  H C Gugnani; J I Okafor
Journal:  Mykosen       Date:  1980-05

5.  Lymphedema and elephantiasis in basidiobolomycosis.

Authors:  A Kamalam; A S Thambiah
Journal:  Mykosen       Date:  1982-09

Review 6.  Basidiobolomycosis: an unusual fungal infection mimicking inflammatory bowel disease.

Authors:  T M Pasha; J A Leighton; J D Smilack; J Heppell; T V Colby; L Kaufman
Journal:  Gastroenterology       Date:  1997-01       Impact factor: 22.682

7.  Successful treatment of subcutaneous phycomycosis with trimethoprim-sulphamethoxazole (Septrin).

Authors:  A K Fomufod; A U Antia
Journal:  Trop Geogr Med       Date:  1971-06

8.  Occurrence of subcutaneous zygomycosis (entomophthoromycosis basidiobolae) caused by Basidiobolus haptosporus with pulmonary involvement.

Authors:  A L Bittencourt; M G Araujo; M S Fontoura
Journal:  Mycopathologia       Date:  1980-07-31       Impact factor: 2.574

9.  Occurrence of subcutaneous zygomycosis caused by Basidiobolus haptosporus in Brazil.

Authors:  A L Bittencourt; A T Londero; M S Araujo; N Mendonca; J L Bastos
Journal:  Mycopathologia       Date:  1979-09-17       Impact factor: 2.574

10.  Subcutaneous zygomycosis caused by Basidiobolus haptosporus: presentation of a case mimicking Burkitt's lymphoma.

Authors:  A L Bittencourt; G Serra; M Sadigursky; M G Araujo; M C Campos; L C Sampaio
Journal:  Am J Trop Med Hyg       Date:  1982-03       Impact factor: 2.345

View more
  35 in total

Review 1.  Unusual fungal and pseudofungal infections of humans.

Authors:  M A Pfaller; D J Diekema
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

2.  Subcutaneous basidiobolomycosis: A Case Report.

Authors:  Adziri Sackey; Nenyin Ghartey; Richard Gyasi
Journal:  Ghana Med J       Date:  2017-03

3.  Fungal diversity in soils across a gradient of preserved Brazilian Cerrado.

Authors:  Ademir Sergio Ferreira de Araujo; Walderly Melgaço Bezerra; Vilma Maria Dos Santos; Luis Alfredo Pinheiro Leal Nunes; Maria do Carmo Catanho Pereira de Lyra; Marcia do Vale Barreto Figueiredo; Vania Maria Maciel Melo
Journal:  J Microbiol       Date:  2017-01-27       Impact factor: 3.422

4.  Gastrointestinal basidiobolomycosis treated with posaconazole.

Authors:  Stacey R Rose; Mark D Lindsley; Steven F Hurst; Christopher D Paddock; Thara Damodaran; John Bennett
Journal:  Med Mycol Case Rep       Date:  2012-11-15

5.  A case of subcutaneous zygomycosis.

Authors:  Usha Rani Anaparthy; G Deepika
Journal:  Indian Dermatol Online J       Date:  2014-01

Review 6.  Zygomycosis: the re-emerging fungal infection.

Authors:  M Chayakulkeeree; M A Ghannoum; J R Perfect
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-04       Impact factor: 3.267

Review 7.  Basidiobolomycosis of the nose and face: a case report and a mini-review of unusual cases of basidiobolomycosis.

Authors:  Arun Goyal; Neelima Gupta; Shukla Das; Sarika Jain
Journal:  Mycopathologia       Date:  2010-04-07       Impact factor: 2.574

Review 8.  Human Pathogenic Entomophthorales.

Authors:  Raquel Vilela; Leonel Mendoza
Journal:  Clin Microbiol Rev       Date:  2018-08-29       Impact factor: 26.132

9.  Basidiobolus: An unusual cause of lung abscess.

Authors:  Ravindran Chetambath; M S Deepa Sarma; K P Suraj; E Jyothi; Safreena Mohammed; Beena J Philomina; S Ramadevi
Journal:  Lung India       Date:  2010-04

10.  Disseminated basidiobolomycosis in an immunocompetent woman.

Authors:  Caterina Bigliazzi; Venerino Poletti; Davide Dell'Amore; Luca Saragoni; Thomas V Colby
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.